Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($) $ in Thousands	Total	IPO [Member]	Common Stock	Preferred Stock	Treasury Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance at Dec. 31, 2020	$ 7,451		$ 1	$ 0		$ 50,096	$ (3)	$ (42,643)
Beginning balance (in shares) at Dec. 31, 2020			66,155,340	0	9,896,666
Shares issued during the period for vested restricted stock awards, Shares			1,169,607
Repurchase of treasury stock			(148,440)		148,440
Issuance of common stock upon exercise of stock options	39					39
Issuance of common stock upon exercise of stock options (in shares)			152,902
Stock-based compensation	449					449
Net Income (loss)	(7,442)							(7,442)
Other comprehensive income (loss)	(1)						(1)
Ending balance at Mar. 31, 2021	496		$ 1	$ 0		50,584	(4)	(50,085)
Ending balance (in shares) at Mar. 31, 2021			67,329,409	0	10,045,106
Beginning balance at Dec. 31, 2021	142,866		$ 9	$ 0		292,082	7	(149,232)
Beginning balance (in shares) at Dec. 31, 2021			92,619,641	0	10,762,566
Shares issued during the period for vested restricted stock awards, Value			$ 1			(1)
Shares issued during the period for vested restricted stock awards, Shares			5,311,326
Issuance of common stock upon exercise of stock options	428					428
Issuance of common stock upon exercise of stock options (in shares)			1,793,876
Issuance of common stock (in shares)		4,455,384
Stock-based compensation	4,610					4,610
Net Income (loss)	(27,793)							(27,793)
Other comprehensive income (loss)	57						57
Ending balance at Mar. 31, 2022	$ 120,168		$ 10	$ 0		$ 297,119	$ 64	$ (177,025)
Ending balance (in shares) at Mar. 31, 2022			99,724,843	0	10,762,566